A citation-based method for searching scientific literature

Lynsey Meikle, Delia M Talos, Hiroaki Onda, Kristen Pollizzi, Alexander Rotenberg, Mustafa Sahin, Frances E Jensen, David J Kwiatkowski. J Neurosci 2007
Times Cited: 311







List of co-cited articles
1091 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures.
Erik J Uhlmann, Michael Wong, Rebecca L Baldwin, M Livia Bajenaru, Hiroaki Onda, David J Kwiatkowski, Kelvin Yamada, David H Gutmann. Ann Neurol 2002
265
25

Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function.
Lynsey Meikle, Kristen Pollizzi, Anna Egnor, Ioannis Kramvis, Heidi Lane, Mustafa Sahin, David J Kwiatkowski. J Neurosci 2008
347
24

Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex.
Ling-Hui Zeng, Lin Xu, David H Gutmann, Michael Wong. Ann Neurol 2008
420
23

The neurology of mTOR.
Jonathan O Lipton, Mustafa Sahin. Neuron 2014
364
23

The tuberous sclerosis complex.
Peter B Crino, Katherine L Nathanson, Elizabeth Petri Henske. N Engl J Med 2006
22

Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2.
Sohail F Tavazoie, Veronica A Alvarez, Dennis A Ridenour, David J Kwiatkowski, Bernardo L Sabatini. Nat Neurosci 2005
351
22

Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study.
Jacqueline A French, John A Lawson, Zuhal Yapici, Hiroko Ikeda, Tilman Polster, Rima Nabbout, Paolo Curatolo, Petrus J de Vries, Dennis J Dlugos, Noah Berkowitz,[...]. Lancet 2016
302
22

mTOR Signaling in Growth, Metabolism, and Disease.
Robert A Saxton, David M Sabatini. Cell 2017
21

Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex.
Ling-Hui Zeng, Nicholas R Rensing, Bo Zhang, David H Gutmann, Michael J Gambello, Michael Wong. Hum Mol Genet 2011
150
19

Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis.
Dan Ehninger, Sangyeul Han, Carrie Shilyansky, Yu Zhou, Weidong Li, David J Kwiatkowski, Vijaya Ramesh, Alcino J Silva. Nat Med 2008
581
19

Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse.
Sharon W Way, James McKenna, Ulrike Mietzsch, R Michelle Reith, Henry Cheng-Ju Wu, Michael J Gambello. Hum Mol Genet 2009
137
18

Tsc2-Rheb signaling regulates EphA-mediated axon guidance.
Duyu Nie, Alessia Di Nardo, Juliette M Han, Hasani Baharanyi, Ioannis Kramvis, Thanhthao Huynh, Sandra Dabora, Simone Codeluppi, Pier Paolo Pandolfi, Elena B Pasquale,[...]. Nat Neurosci 2010
174
18

Tuberous sclerosis complex proteins control axon formation.
Yong-Jin Choi, Alessia Di Nardo, Ioannis Kramvis, Lynsey Meikle, David J Kwiatkowski, Mustafa Sahin, Xi He. Genes Dev 2008
185
18

Hypomyelination following deletion of Tsc2 in oligodendrocyte precursors.
Robert P Carson, Nathaniel D Kelm, Kathryn L West, Mark D Does, Cary Fu, Grace Weaver, Eleanor McBrier, Brittany Parker, Mark D Grier, Kevin C Ess. Ann Clin Transl Neurol 2015
39
46

Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice.
Peter T Tsai, Court Hull, YunXiang Chu, Emily Greene-Colozzi, Abbey R Sadowski, Jarrett M Leech, Jason Steinberg, Jacqueline N Crawley, Wade G Regehr, Mustafa Sahin. Nature 2012
483
17

Neuronal CTGF/CCN2 negatively regulates myelination in a mouse model of tuberous sclerosis complex.
Ebru Ercan, Juliette M Han, Alessia Di Nardo, Kellen Winden, Min-Joon Han, Leonie Hoyo, Afshin Saffari, Andrew Leask, Daniel H Geschwind, Mustafa Sahin. J Exp Med 2017
49
34

Excitatory/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis.
Helen S Bateup, Caroline A Johnson, Cassandra L Denefrio, Jessica L Saulnier, Karl Kornacker, Bernardo L Sabatini. Neuron 2013
205
17

The natural history of epilepsy in tuberous sclerosis complex.
Catherine J Chu-Shore, Philippe Major, Susana Camposano, David Muzykewicz, Elizabeth A Thiele. Epilepsia 2010
344
17

Neurological and neuropsychiatric aspects of tuberous sclerosis complex.
Paolo Curatolo, Romina Moavero, Petrus J de Vries. Lancet Neurol 2015
273
16

Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin.
Robert P Carson, Dominic L Van Nielen, Peggy A Winzenburger, Kevin C Ess. Neurobiol Dis 2012
105
16

Sustained activation of mTOR pathway in embryonic neural stem cells leads to development of tuberous sclerosis complex-associated lesions.
Laura Magri, Marco Cambiaghi, Manuela Cominelli, Clara Alfaro-Cervello, Marco Cursi, Mauro Pala, Alessandro Bulfone, Jose Manuel Garcìa-Verdugo, Letizia Leocani, Fabio Minicucci,[...]. Cell Stem Cell 2011
161
15

Single-cell Tsc1 knockout during corticogenesis generates tuber-like lesions and reduces seizure threshold in mice.
David M Feliciano, Tiffany Su, Jean Lopez, Jean-Claude Platel, Angélique Bordey. J Clin Invest 2011
109
15

mTORC1 Inhibition Corrects Neurodevelopmental and Synaptic Alterations in a Human Stem Cell Model of Tuberous Sclerosis.
Veronica Costa, Stefan Aigner, Mirko Vukcevic, Evelyn Sauter, Katharina Behr, Martin Ebeling, Tom Dunkley, Arno Friedlein, Sannah Zoffmann, Claas A Meyer,[...]. Cell Rep 2016
57
26

Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex.
June Goto, Delia M Talos, Peter Klein, Wei Qin, Yvonne I Chekaluk, Stefanie Anderl, Izabela A Malinowska, Alessia Di Nardo, Roderick T Bronson, Jennifer A Chan,[...]. Proc Natl Acad Sci U S A 2011
117
14

Balanced mTORC1 activity in oligodendrocytes is required for accurate CNS myelination.
Frédéric Lebrun-Julien, Lea Bachmann, Camilla Norrmén, Martin Trötzmüller, Harald Köfeler, Markus A Rüegg, Michael N Hall, Ueli Suter. J Neurosci 2014
99
13

TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1.
Christian C Dibble, Winfried Elis, Suchithra Menon, Wei Qin, Justin Klekota, John M Asara, Peter M Finan, David J Kwiatkowski, Leon O Murphy, Brendan D Manning. Mol Cell 2012
372
13

Loss of Tsc1 in vivo impairs hippocampal mGluR-LTD and increases excitatory synaptic function.
Helen S Bateup, Kevin T Takasaki, Jessica L Saulnier, Cassandra L Denefrio, Bernardo L Sabatini. J Neurosci 2011
148
13

Loss of white matter microstructural integrity is associated with adverse neurological outcome in tuberous sclerosis complex.
Jurriaan M Peters, Mustafa Sahin, Vanessa K Vogel-Farley, Shafali S Jeste, Charles A Nelson, Matthew C Gregas, Sanjay P Prabhu, Benoit Scherrer, Simon K Warfield. Acad Radiol 2012
81
14

Cognitive deficits in Tsc1+/- mice in the absence of cerebral lesions and seizures.
Susanna M I Goorden, Geeske M van Woerden, Louise van der Weerd, Jeremy P Cheadle, Ype Elgersma. Ann Neurol 2007
180
12

Developmental brain abnormalities in tuberous sclerosis complex: a comparative tissue analysis of cortical tubers and perituberal cortex.
Véronique Ruppe, Pelin Dilsiz, Carol Shoshkes Reiss, Chad Carlson, Orrin Devinsky, David Zagzag, Howard L Weiner, Delia M Talos. Epilepsia 2014
63
19

Genomic analysis of the molecular neuropathology of tuberous sclerosis using a human stem cell model.
Nils Grabole, Jitao David Zhang, Stefan Aigner, Nadine Ruderisch, Veronica Costa, Felix C Weber, Michel Theron, Nikolaos Berntenis, Olivia Spleiss, Martin Ebeling,[...]. Genome Med 2016
24
50

Mutations causing syndromic autism define an axis of synaptic pathophysiology.
Benjamin D Auerbach, Emily K Osterweil, Mark F Bear. Nature 2011
413
12

A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells.
David J Kwiatkowski, Hongbing Zhang, Jennifer L Bandura, Kristina M Heiberger, Michael Glogauer, Nisreen el-Hashemite, Hiroaki Onda. Hum Mol Genet 2002
490
11

Tuberous sclerosis complex.
Elizabeth P Henske, Sergiusz Jóźwiak, J Christopher Kingswood, Julian R Sampson, Elizabeth A Thiele. Nat Rev Dis Primers 2016
222
11

Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits.
Guomei Tang, Kathryn Gudsnuk, Sheng-Han Kuo, Marisa L Cotrina, Gorazd Rosoklija, Alexander Sosunov, Mark S Sonders, Ellen Kanter, Candace Castagna, Ai Yamamoto,[...]. Neuron 2014
538
11

The TSC1-TSC2 complex: a molecular switchboard controlling cell growth.
Jingxiang Huang, Brendan D Manning. Biochem J 2008
785
11

The genomic landscape of tuberous sclerosis complex.
Katie R Martin, Wanding Zhou, Megan J Bowman, Juliann Shih, Kit Sing Au, Kristin E Dittenhafer-Reed, Kellie A Sisson, Julie Koeman, Daniel J Weisenberger, Sandra L Cottingham,[...]. Nat Commun 2017
90
12

Neuron-Glia Interactions Increase Neuronal Phenotypes in Tuberous Sclerosis Complex Patient iPSC-Derived Models.
Aishwarya G Nadadhur, Mouhamed Alsaqati, Lisa Gasparotto, Paulien Cornelissen-Steijger, Eline van Hugte, Stephanie Dooves, Adrian J Harwood, Vivi M Heine. Stem Cell Reports 2019
37
29


Tsc2(+/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background.
H Onda, A Lueck, P W Marks, H B Warren, D J Kwiatkowski. J Clin Invest 1999
289
10

Genetically engineered human cortical spheroid models of tuberous sclerosis.
John D Blair, Dirk Hockemeyer, Helen S Bateup. Nat Med 2018
74
13

mTOR signaling in growth control and disease.
Mathieu Laplante, David M Sabatini. Cell 2012
9

Impaired language pathways in tuberous sclerosis complex patients with autism spectrum disorders.
William W Lewis, Mustafa Sahin, Benoit Scherrer, Jurriaan M Peters, Ralph O Suarez, Vanessa K Vogel-Farley, Shafali S Jeste, Matthew C Gregas, Sanjay P Prabhu, Charles A Nelson,[...]. Cereb Cortex 2013
45
20

Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling.
Ken Inoki, Yong Li, Tian Xu, Kun-Liang Guan. Genes Dev 2003
9

Loss of Tsc2 in Purkinje cells is associated with autistic-like behavior in a mouse model of tuberous sclerosis complex.
R Michelle Reith, James McKenna, Henry Wu, S Shahrukh Hashmi, Seo-Hee Cho, Pramod K Dash, Michael J Gambello. Neurobiol Dis 2013
104
9

Neuropathology of tuberous sclerosis.
M Mizuguchi, S Takashima. Brain Dev 2001
135
9

Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis.
Darcy A Krueger, Marguerite M Care, Katherine Holland, Karen Agricola, Cynthia Tudor, Prajakta Mangeshkar, Kimberly A Wilson, Anna Byars, Tarek Sahmoud, David Neal Franz. N Engl J Med 2010
644
9

Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model.
N Lozovaya, S Gataullina, T Tsintsadze, V Tsintsadze, E Pallesi-Pocachard, M Minlebaev, N A Goriounova, E Buhler, F Watrin, S Shityakov,[...]. Nat Commun 2014
65
13

Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia.
Alissa M D'Gama, Ying Geng, Javier A Couto, Beth Martin, Evan A Boyle, Christopher M LaCoursiere, Amer Hossain, Nicole E Hatem, Brenda J Barry, David J Kwiatkowski,[...]. Ann Neurol 2015
156
9

Biallelic TSC gene inactivation in tuberous sclerosis complex.
Peter B Crino, Eleonora Aronica, Gordon Baltuch, Katherine L Nathanson. Neurology 2010
106
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.